DRKS00010169
Recruiting
Not Applicable
Identification of neutralizing antibodies against severe or chronic infections of human being - INA
niversitätsklinikum Köln0 sites1,000 target enrollmentApril 13, 2016
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversitätsklinikum Köln
- Enrollment
- 1000
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients suffering from chronic infections or passing trough severe infections within the last 10 years or healthy people as volunteers, and Karnofsky \> 80
Exclusion Criteria
- •\-Leukopenia \< 2\.000 Leukocytes/µl
- •\-Hb \< 10 g/dl
- •\-Platelets \< 50\.000 Plateelts/µl
- •\-Known acquired or hereditary coagulation disorder, including anticoaguant treatment
- •\-CHF NYHA II\-IV
- •\-COPD GOLD Stadium III\-IV
- •\-History of myocardial infarcation or current symptomatic coronary artery disease
- •\-Symptomatic cardiac or pulmonary disease
- •\-Body weight below 45 kg (for an apheresis or blood draw of \> 250 mL, a body weight of 50 kg is required)
- •\-\< 8 (men) or 12 (women) weeks since last blood donation or blood draw volume of \> 100 mL
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
Generation of broadly neutralizing antibodies for the development of an enterovirus immunotherapyenterovirus infectionsviral infections10047438NL-OMON45608Academisch Medisch Centrum25
Completed
Not Applicable
Survey of IgG and neutralizing antibodies against SARS-CoV-2 variants in adults after vaccinatioCOVID-19JPRN-UMIN000045405Research Center for Immunological Analysis, Inc.40
Recruiting
Not Applicable
The seroprevalence of neutralizing antibody against Japanese encephalitis virus in health care workersJapanese encephalitis riskJapanese encephalitisSeroprevalenceSeroepidemiologySerological studyBangkokadultshealthcare workersThailandTCTR20151017004Sanofi Pasteur, Thailand400
Enrolling By Invitation
Not Applicable
The seroprevalence of neutralizing antibody against Dengue virus in health care workersDengue fever riskDenguePRNTNeutralizing antibodySeroprevalenceSeroepidemiologySerological studyBangkokadultshealthcare workersThailandTCTR20160303002Sanofi Pasteur, Thailand402
Not yet recruiting
Not Applicable
Detection of Neutralizing Antibody Against SARS-CoV-2 in RT-PCR Confirmed COVID-19 Patient with Diverse Disease SeverityCOVID-19TCTR20210329003King Chulalongkorn Memorial Hospital Excellence Center Program,36